Lorlatinib(Lorbrena)

Another NameLorviqua、劳拉替尼

IndicationsLorlatinib is indicated for the treatment of adult patients with non-small cell lung cancer (NSCLC) that is caused by anaplastic lymphoma kinase (ALK) gene abnormalities and has metastasized to other